YANKUANG ENER.GR.H ADR/10/ US9848461052 /
2024-05-14 12:20:01 PM | Chg. -0.800 | Volume | Bid12:20:07 PM | Ask12:20:07 PM | High | Low |
---|---|---|---|---|---|---|
22.400EUR | -3.45% | 0 Turnover: 0.000 |
21.600Bid Size: 455 | 23.400Ask Size: 420 | 22.800 | 22.400 |
GlobeNewswire
1:45 PM
Global Technologies, Ltd. Announces Its Financial Results for the Quarter Ended March 31, 2024 and t...
Newsfile Corp
1:44 PM
Appia Announces Encouraging Initial Results from the Newly Identified Taygeta and Merope Exploration...
GlobeNewswire
1:30 PM
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire
1:30 PM
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire
1:30 PM
ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire
1:30 PM
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire
1:30 PM
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
1:30 PM
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
1:30 PM
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
1:30 PM
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire
1:30 PM
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
1:30 PM
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
GlobeNewswire
1:30 PM
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results